NEVVI Medicare utilization intelligence

← back

CHAUDHRY, ARVINDMD NPI 1750336236 Clinician

Hematology-Oncology · SPOKANE, WA

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 43 years since medical school (class of 1983, self-reported to CMS)
Location SPOKANE, WA · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 49 codes billed · 101,047 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MEDICAL ONCOLOGY ASSOCIATES PS
2025–2026
AMERICAN ONCOLOGY PARTNERS PA
2021–2025
MEDICAL ONCOLOGY ASSOCIATES PS
2019–2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-07

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9271 Injection, pembrolizumab, 1 mg
J0185 Injection, aprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
96375 Injection of additional new drug or substance into vein
80053 Blood test, comprehensive group of blood chemicals
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
J2405 Injection, ondansetron hydrochloride, per 1 mg
Q5130 Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96372 Injection of drug or substance under skin or into muscle
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
71260 Ct scan of chest with contrast
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
74177 Ct scan of abdomen and pelvis with contrast
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96415 Administration of chemotherapy into vein, each additional hour
J3489 Injection, zoledronic acid, 1 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
83615 Lactate dehydrogenase (enzyme) level
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96523 Irrigation of implanted venous access drug delivery device
83735 Magnesium level
71250 Ct scan of chest without contrast
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
74176 Ct scan of abdomen and pelvis without contrast
81002 Urinalysis, manual test
99195 Drawing of blood for a medical problem
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.